ACLY-IN-2 (Compound 7) has inhibitory effect against human ATP citrate lyase (hACLY), with an IC50 of less than 1 nM. ACLY-IN-2 can be studied in research on liver-related diseases, type-2 diabetes, autoimmunity, and cancer[1].
Molekulargewicht:
481.85
CAS Nummer:
[3009136-86-8]
Formel:
C21H14ClF2NO6S
Target-Kategorie:
ATP Citrate Lyase
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten